Last reviewed · How we verify
Steroid Eye Drops in Chronic Central Serous Chorioretinopathy (PICS)
In this pilot study the effect and safety of the use of steroid eye drops in chronic central serous chorioretinopathy (cCSC) will be evaluated. The study is conducted as a randomized single-blind placebo-controlled trial. Forty patients will be randomized to either steroid eye drops or placebo eye drops. Patients will self-administer the eye drops three times a day for four weeks.
Details
| Lead sponsor | Radboud University Medical Center |
|---|---|
| Phase | PHASE3 |
| Status | RECRUITING |
| Enrolment | 40 |
| Start date | Sun Feb 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jul 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Chronic Central Serous Chorioretinopathy
Interventions
- steroid eye drops
- Placebo
Countries
Netherlands